meQTL Discovery in Admixed Human Genomes Facilitates Estimates of Epistasis
Project Number1R21HG013565-01
Contact PI/Project LeaderHENN, BRENNA M
Awardee OrganizationUNIVERSITY OF CALIFORNIA AT DAVIS
Description
Abstract Text
Personalized genetics is poised to revolutionize healthcare; however, despite advances, genetic
prediction and portability of critical variants remains too limited for clinical use. Genetic
prediction is error-prone when applied to individuals with genetic ancestries different from
discovery cohorts, often predicting disease risk little better than random in non-European
samples. We propose understanding an underlying cause of this loss of prediction accuracy by
assessing the extent of GxG interaction effects across ancestries. Using an innovative
approach, we tackle this statistically challenging problem by 1) modeling effect sizes of meQTLs
on different ancestry haplotypes in an admixed African sample from the same population --
thereby controlling for GxE, and 2) using highly heritable genome-wide methylation phenotypes,
affording us thousands of observations per participant rather than a single phenotype (e.g.
presence of cardiovascular disease). Our study design allows us to assess whether the
presence of ancestry-dependent interactions is a common factor in the variability of SNP effect
sizes across populations. Outcomes of this grant include: generating a large genome-wide
methylation dataset from 500 admixed South Africans, paired with underlying genome-wide
DNA variation. We will further estimate the fraction of meQTLs with ancestry-specific effects and
thereby comprehensively provide a snapshot of the frequency of GxG interactions in the human
genome. These results will motivate investigation of GxG effects in a broader set of biomedical
phenotypes and the extent to which they contribute to poor portability of polygenic risk across
populations.
Public Health Relevance Statement
Project Narrative
The clinical benefits of precision medicine have been limited because genetic
predictions in people with ancestries different from the overwhelmingly European-
ancestry discovery cohorts are highly error prone. Among the possible factors that can
cause this portability issue, gene-by-gene interaction or “epistasis”, has received much
less attention as compared to differences in linkage disequilibrium or population-specific
causal variants. This study will estimate the extent that gene-by-gene interactions
impact phenotypic variation by testing for ancestry-specific effects on methylation in an
admixed African population.
No Sub Projects information available for 1R21HG013565-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21HG013565-01
Patents
No Patents information available for 1R21HG013565-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21HG013565-01
Clinical Studies
No Clinical Studies information available for 1R21HG013565-01
News and More
Related News Releases
No news release information available for 1R21HG013565-01
History
No Historical information available for 1R21HG013565-01
Similar Projects
No Similar Projects information available for 1R21HG013565-01